Health Canada drug identification number

DIN 02442183 — VARIZIG 125 UNIT

VARIZIG is a solution of Varicella Zoster Immunoglobulin marketed by KI BIOPHARMA LLC. The full Varicella Zoster Immunoglobulin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02442183
Brand name
VARIZIG
Strength
125 UNIT
Dosage form
SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Manufacturer
KI BIOPHARMA LLC
Health Canada status
MARKETED
Drug class
Human plasma-derived immunoglobulin (passive immunizing agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.